FGFR2 and esophageal adenocarcinoma: In support of its role as a candidate driver, FGFR2 amplification is present in a number of gastric cancer cell lines [28,29] and subsequently reported in various gastrointestinal malignancies such as esophageal adenocarcinoma [30].